Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke
Open Access
- 2 September 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 9, 344
Abstract
In the treatment of acute ischemic stroke, vessel recanalization correlates with improved functional status and reduced mortality. Mechanical neurothrombectomy achieves a higher likelihood of revascularization than intravenous thrombolysis, but there remains significant discrepancy between rates of recanalization and rates of favorable outcome. The poor neurological recovery among some stroke patients despite successful recanalization confirms the need for adjuvant therapy, such as pharmacological neuroprotection. Prior clinical trials of neuroprotectant drugs failed perhaps due to inability of the agent to reach the ischemic tissue beyond the occluded artery. A protocol that couples mechanical neurothrombectomy with concurrent delivery of a neuroprotectant overcomes this pitfall. Activated protein C (APC) exerts pleiotropic anti-inflammatory, anti-apoptotic, antithrombotic, cytoprotective, and neuroregenerative effects in stroke and appears a compelling candidate for this novel approach.Keywords
This publication has 64 references indexed in Scilit:
- Endovascular Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2013
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet, 2012
- Cytoprotective protein C pathways and implications for stroke and neurological disordersTrends in Neurosciences, 2011
- Activated Protein C is Neuroprotective and Mediates New Blood Vessel Formation and Neurogenesis After Controlled Cortical ImpactNeurosurgery, 2010
- Good clinical outcome after ischemic stroke with successful revascularization is time-dependentNeurology, 2009
- Differential Neuroprotection and Risk for Bleeding From Activated Protein C With Varying Degrees of Anticoagulant ActivityStroke, 2009
- Current Status of Neuroprotection for Cerebral IschemiaStroke, 2009
- Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1Journal of Neuroscience, 2008
- Endothelial Protein C Receptor-Assisted Transport of Activated Protein C across the Mouse Blood—Brain BarrierJournal of Cerebral Blood Flow & Metabolism, 2008
- Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotectiveNature Medicine, 2003